Repositioning of FDA Approved Drugs in Breast Cancer. IJFANS [Internet]. 2022 Jan. 1 [cited 2026 Sep. 7];11(Special Issue 2):893-905. Available from: https://ijfans.org/index.php/Journal/article/view/8125